CAMBRIDGE EPIGENETIX Ltd of Cambridge, X0, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-09. The offering totals $12.3M, of which $12.3M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Shankar Balasubramanian | Director | Cambridge, X0 |
| Thomas Hulme | Director | Cambridge, X0 |
| Jason Mellad | Director | Cambridge, X0 |
| Martin Murphy | Director | Cambridge, X0 |
| Alice Newcombe-Ellis | Director | Cambridge, X0 |
| Timothy Rink | Director | Cambridge, X0 |
| Somasundaram Subramaniam | Director | San Diego, CA |
| Bobby Yerramilli-Rao | Director | Cambridge, X0 |
| Jason Mellad | Executive Officer | Cambridge, X0 |